semaglutide compounding fda Hims & Hers stock falls 25% as curtails compounded GLP-1s Semaglutide | NextGenRx Compound Pharmacy

Investigators reported that 45.3% of participants on the 12 mg arm achieved 30% body-weight reduction over the 80-week trial period [1][2]

Phase 2 clinical trials showed weight loss of up to -24.2% over 48 weeks

*FOR DO WEIGHT-LOSS PILLS WORK SOURCE: National Institute of Diabetes and Digestive and Kidney Diseases (NIH/NIDDK)

If progress grinds to a halt or side effects rear their heads, this schedule can be shortened

ClinicalTrials.gov: NCT04881760), participants receiving the highest dose of retatrutide demonstrated mean body weight reductions of approximately 24% over 48 weeks among the most significant weight-loss outcomes observed in pharmacological trials to date